Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Regenerative Medicine|December 16, 2011
Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process developmentJessica Carmen, Scott R Burger, Michael McCaman, et al.Cytotherapy|December 25, 2012
Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industryChristopher A Bravery, Jessica Carmen, Timothy Fong, et al.Regenerative Medicine|October 6, 2018
Corporate profile: RoosterBio, IncTimothy R Olsen, Jon A RowleyJournal of Biomedical Materials Research|February 22, 2002
Alginate type and RGD density control myoblast phenotypeJon A Rowley, David J MooneyAnalytical Biochemistry|October 3, 2006
Precise and comparative pegylation analysis by microfluidics and mass spectrometryTao Yu, Joseph A Traina, Erno Pungor, et al.Advances in Biochemical Engineering/Biotechnology|August 13, 2013
Therapeutic human cells: manufacture for cell therapy/regenerative medicineChristian van den Bos, Robert Keefe, Carmen Schirmaier, et al.Plos One|February 6, 2014
Scalable passaging of adherent human pluripotent stem cellsYing Nie, Patrick Walsh, Diana L Clarke, et al.Proceedings of the National Academy of Sciences of the United States of America|September 10, 2002
Engineering growing tissuesEben Alsberg, Kenneth W Anderson, Amru Albeiruti, et al.Journal of Immunological Methods|December 21, 2014
Quantitation of residual trypsin in cell-based therapeutics using immobilized α-1-antitrypsin or SBTI in an ELISA formatJames A Braatz, Christopher Elias, Joseph G Finny, et al.Frontiers in Medicine|July 7, 2018
Peak MSC-Are We There Yet?Timothy R Olsen, Kelvin S Ng, Lye T Lock, et al.Pageof 3